Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of a breast cancer risk judgement platform designed to reduce the risk of breast cancer. The company's breast cancer risk judgement platform uses machine learning and computer vision to deliver risk models and automated physician annotation through the use of mammograms, enabling women to assess the risk of breast cancer.
You’re viewing a free company profile from the PitchBook Platform. To explore VisExcell’s full profile, request a free trial.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Early Stage VC | 04-Mar-2016 | $600K | 00000 | Completed | Startup | |
1. Accelerator/Incubator | 26-Oct-2015 | 0000 | 0000 | 00000 | Completed | Startup |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
---|---|---|---|---|---|---|
DreamIt Ventures | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
Name | Representing | Role | Since | Contact Info |
---|---|---|---|---|
Elizabeth Haynes | VisExcell | Board Member & Executive Officer | 000 0000 | |
Mahender Nathan | VisExcell | Co-Founder, Board Member & President | 000 0000 | |
Steve Moore | VisExcell | Co-Founder, Board Member & Vice President of Technology Research & Development | 000 0000 |